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Highly branched poly(β-amino ester) delivery of
minicircle DNA for transfection of
neurodegenerative disease related cells
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Current therapies for most neurodegenerative disorders are only symptomatic in nature and
do not change the course of the disease. Gene therapy plays an important role in disease
modifying therapeutic strategies. Herein, we have designed and optimized a series of highly
branched poly(β-amino ester)s (HPAEs) containing biodegradable disulﬁde units in the HPAE
backbone (HPAESS) and guanidine moieties (HPAESG) at the extremities. The optimized
polymers are used to deliver minicircle DNA to multipotent adipose derived stem cells
(ADSCs) and astrocytes, and high transfection efﬁciency is achieved (77% in human ADSCs
and 52% in primary astrocytes) whilst preserving over 90% cell viability. Furthermore, the
top-performing candidate mediates high levels of nerve growth factor (NGF) secretion from
astrocytes, causing neurite outgrowth from a model neuron cell line. This synergistic gene
delivery system provides a viable method for highly efﬁcient non-viral transfection of ADSCs
and astrocytes.
https://doi.org/10.1038/s41467-019-11190-0 OPEN
1 Charles Institute of Dermatology, School of Medicine, University College Dublin, Belﬁeld, 4 Dublin, Ireland. 2 Key Laboratory of Functional Polymer Materials,
Ministry of Education, Institute of Polymer Chemistry, College of Chemistry, Nankai University, 300071 Tianjin, China. 3 School of Chemical Engineering and
Technology, Xiʹan Jiaotong University, 710049 Xiʹan, China. 4 School of Pharmacy and Pharmaceutical Sciences, Cardiff University, CF103AT Cardiff, UK.
5 School of Pharmaceutical Science, Zhejiang University of Technology, 310014 Hangzhou, China. 6 Department of Polymer Science and Engineering, Zhejiang
University, 310027 Hangzhou, China. 7These authors contributed equally: Shuai Liu, Yongsheng Gao, Dezhong Zhou. Correspondence and requests for
materials should be addressed to D.Z. (email: dezhong.zhou@ucd.ie) or to T.G. (email: tyguo@nankai.edu.cn) or to W.W. (email: wenxin.wang@ucd.ie)
NATURE COMMUNICATIONS |         (2019) 10:3307 | https://doi.org/10.1038/s41467-019-11190-0 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Cell and gene therapies have been considered for a range ofneurological disorders1,2. Transplanted cells can either beused to secrete factors such as neurotrophic/neuropro-
tective agents, or they can be used to replace lost cell types3,4.
Manipulating stem cells to further improve their beneﬁcial
secretome by overexpressing neuroprotrophic/neuroprotective
growth factors prior to transplantation (ex vivo manipulation) is
an attractive strategy for neural repair5–7. Alternatively, directly
transfecting a major support cell (such as astrocytes) in vivo
would allow secretion of factors to support damaged neurons8.
One major hurdle for both strategies arises due to the fact that
these cell types are typically hard to transfect.
Adipose-derived stem cells (ADSCs) are easy to isolate, expand
and engraft, and can secrete a broad spectrum of angiogenic,
neurotrophic factors and chemokines9. They are therefore an
exciting cell resource for neural tissue regeneration with good
clinical applicability10,11. ADSCs also have the ability to regulate
the inﬂammatory response and hold antioxidant capacity12.
Moreover, under the induction of speciﬁc genetic signals, ADSCs
can differentiate into neuron-like or glia-like cells13,14. However,
ADSCs are difﬁcult to transfect14, thus driving the design of
better gene delivery systems. Astrocytes are also hard to transfect
showing far lower levels of transgene expression than other cell
types15,16, making direct gene transfer into the brain somewhat
limited17.
Gene transfection vectors, especially non-viral vectors have
attracted increasing attention because of high safety proﬁle, large
gene loading capacity and ease of large-scale production18–21, but
are consistently plagued by the unsatisﬁed gene transfection
capability22–24. Lynn and Langer25 developed linear poly(β-
amino ester)s (LPAEs) through the conjugation addition of
amines to diacrylates. Owing to the broad monomer availability,
the chemical composition of LPAEs is highly tailorable, and so far
more than 2350 LPAEs have been developed26–28. The top-
performing LPAE series have demonstrated their high
gene transfection potency and biocompatibility on a variety of cell
types29–31. In-depth mechanistic studies illustrate that the term-
inal units of LPAEs play a critical role in achieving high
gene transfection efﬁciency28,32. For example, by altering the
alcohol terminals to primary amines, the transfection efﬁciency
can be improved by three orders-of-magnitude33,34.
As such, one can now envisage that dendritic poly(β-
amino ester)s could be more conducive for efﬁcient gene trans-
fection, because, unlike LPAEs with only two terminals, dendritic
poly(β-amino ester)s contain multiple terminal units. The three-
dimensional (3D) topological structure of dendritic poly(β-
amino ester)s would provide a large chemical space for functio-
nalization and would be more favorable for DNA condensation
and protection from enzymatic degradation35. As such, recently
we have developed highly branched poly(β-amino ester)s
(HPAEs) as gene delivery vectors36–39. Both in vitro and in vivo
studies demonstrated the high efﬁciency of HPAEs in gene
transfection. Importantly, the inherent nature of highly branched
structure: multiple terminal groups makes HPAEs a highly ﬂex-
ible and tailorable platform for the development of various
functionality-enhanced gene delivery vectors aiming at different
clinical targets.
Aside from the vector, the DNA cassette itself also plays a
crucial role in determining overall gene transfection safety and
efﬁciency. For instance, earlier results showed that by removing
the prokaryotic sequences, minicircle DNA constructs (MC
DNA), a supercoiled minimally sized DNA cassette, were
capable of mediating a prolonged non-integrative transgene
expression40,41.
The goal of this work is therefore to develop multifunctional
HPAEs and combine them with a MC DNA for high-
performance gene transfection of ADSCs and astrocytes. We
aim to navigate the three key barriers associated with gene
delivery: cytotoxicity, polyplex cellular uptake and DNA release.
It is hypothesized that by integrating multiple disulﬁde bonds
into HPAE backbone (HPAESS), glutathione-mediated biode-
gradation can be achieved. This will not only facilitate DNA
release from HPAE/DNA polyplexes but also reduce the cyto-
toxicity of HPAEs after transfection. By adding guanidine groups
to the terminals of HPAEs (HPAESG), the formation of multiple
hydrogen bonds between guanidine moieties and polyhydroxyl
compounds or heparan sulfate on the cell membrane will enhance
cellular uptake of polyplexes. Three optimization steps are carried
out (depicted in Fig. 1), with each being subjected to an iterative
screening process, allowing assessment of the synergy between
each modiﬁcation. Optimization of the branched structure, dis-
ulﬁde bond content, and guanidinylation degree leads to a
HPAESG, which, combining with MC DNA, gives a far superior
transfection proﬁle in both ADSCs and primary astrocytes.
Results
Identiﬁcation of the optimal HPAEs for gene transfection.
Numerous studies have demonstrated that for branched poly-
meric gene vectors, the different topological structures have
substantial effects on DNA binding afﬁnity and size, zeta
potential and morphology of polyplexes, all of which are relevant
to the ultimate transfection efﬁciency and cytotoxicity36,42. To
better understand the structure-property relationship and deter-
mine the optimal branched structure for sequential functionali-
zation, we began by synthesizing HPAEs with gradually transited
structures. By utilizing 4-amino-1-butanol (S4) and bisphenol A
ethoxylate diacrylate (BE) as functional monomers and varying
the content of the branching monomer trimethylolpropane tria-
crylate (TMPTA) in the feed ratio, we prepared a total of ﬁve
HPAEs and one LPAE with similar molecular weights (Supple-
mentary Tables 1 and 2 and Supplementary Figs. 1 and 2). As the
TMPTA feed ratio increases (Supplementary Table 2), the evo-
lution of the molecular weight of the corresponding HPAE-based
polymer becomes faster, as reﬂected by the gel permeation
chromatography (GPC) curves (Supplementary Fig. 3), indicating
the acceleration of oligomer combinations by increasing the
branching unit amount. The attempt to calculate the branching
degree (BD) from nuclear magnetic resonance (NMR) spectra
(Supplementary Fig. 2) was failed due to the identical chemical
environment of the three vinyl groups in TMPTA (Supplemen-
tary Fig. 4). Instead, Mark-Houwink plots of the HPAEs were
measured and the exponent (α) values were extracted to compare
their extents of branching. As shown in Supplementary Table 2
and Supplementary Fig. 5, the α value for HPAE-1 to HPAE-5
was 0.48, 0.46, 0.44, 0.37, and 0.32, respectively, which was less
than that of LPAE: 0.63, demonstrating the dendritic nature of
HPAEs. Moreover, smaller α values were obtained from those
HPAEs with higher TMPTA to BE feed ratios, corresponding to
more spherical morphologies and thereby higher branching
degrees. It is noteworthy that, although those HPAEs have broad
molecular weight distributions with dispersity (Đ) values ranging
from 2.94 to 6.80, which is a common feature for polymers from
polycondesation reations43,44, their branched structures and
molecular weights are consistent from batch to batch as shown in
Supplementary Fig. 6 and Supplementary Table 3, highlighting
their potential for the clinical applications.
Next, we characterized and compared three physiological
properties of the polymer/DNA polyplexes: binding efﬁciency,
size and surface charge. Picogreen assays showed that at polymer/
DNA weight ratios (w/w) of 10:1 and 20:1, all polymers showed a
strong DNA binding afﬁnity (Fig. 2a). Dynamic light scattering
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(DLS) measurements further showed that all the polyplexes had
sizes less than 250 nm (Fig. 2b). Of all the HPAE/DNA
polyplexes, HPAE-3/DNA were slightly smaller than the other
HPAE counterparts. The stability of LPAE/DNA and HPAE-3/
DNA polyplexes (w/w= 20:1) was also tested. As shown in
Supplementary Fig. 7, HPAE-3/DNA polyplexes remained stable
in the presence of bovine serum albumin (BSA). Whereas, sizes of
LPAE/DNA polyplexes increased dramatically, which is corre-
lated to a recent observation by Anderson and colleagues45. With
respect to the surface charge, all the polyplexes showed moderate
positive zeta potentials (Fig. 2c). We speculate that the deviation
in polyplex size and zeta potential between HPAEs and LPAE is
possibly due to the different interaction mechanisms of polymers
with DNA. As the branching degree increases, the polymers
gradually transit from a linear, ﬂexible structure to a globular,
more rigid structure, meanwhile the number of terminal primary
amines per polymer molecule also increases, contributing to the
rise in positive charge. Since the DNA chain is highly charged and
rigid because of the electrostatic repulsion, and HPAEs are
globular, they perhaps condense DNA into a toroidal nano-ring
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structure, as opposed to LPAEs condensing the DNA into a more
compact/spherical nanoparticle of smaller size. To validate our
speculation, we used transmission electron microscopy (TEM) to
observe the morphologies of different polyplexes. As shown in
Fig. 2d, the HPAE-3/DNA polyplexes manifested a uniform and
toroidal morphology while the LPAE/DNA counterparts showed
a spherical morphology. We believe that the different size, zeta
potential as well as morphologies would lead to different cellular
uptake efﬁciency of polyplexes. Using Cy3 (a red ﬂuorescence
dye, used for DNA labeling) and Lyso-Tracker Green (a green
ﬂuorescence indicator of endo/lysosomes) as reporters, we
showed that on HeLa cells, HPAE/DNA polyplexes indeed have
a higher cellular uptake efﬁciency than the LPAE/DNA counter-
parts (Fig. 2e). The endo/lysosomal escape ability of the
polyplexes was also compared by quantifying the Person
correlation coefﬁcient (PCC) using Image J. As shown in
Supplementary Fig. 8, at the w/w ratio of 20:1, the average PCC
of the HPAE-3/DNA and LPAE/DNA polyplexes calculated from
three representative cell images were 0.30 and 0.62, respectively.
The much lower PCC indicates that the HPAE-3/DNA polyplexes
exhibit a stronger endo/lysosomal escape ability in comparison
with the LPAE/DNA counterparts.
The gene transfection efﬁciency of the HPAEs was evaluated
on HKC8 and HeLa cells, with three widely used commercial
transfection reagents polyethylenimine (PEI), SuperFect and
Lipofectamine 2000 (Lipo2k) as positive controls. As shown in
Fig. 3a, Gluciferase activity of cells after transfection with HPAEs
was substantially higher than that of the LPAE. Moreover, at the
w/w ratio of 20:1, all HPAEs outperformed the three commercial
reagents and orders-of-magnitude higher Gluciferase activity was
observed. The images of cells after transfection with green
ﬂuorescent protein (GFP) further validated the high-transfection
capability of the HPAE library (Fig. 3b–d and Supplementary
Figs. 9 and 10). Our results conclude that the branched structure
is much more conducive for gene transfection, with a relatively
moderate branching degree (HPAE-3) showing higher transfec-
tion capability than the more branched HPAE-4 and HPAE-5 or
less branched HPAE-1 and HPAE-2. This trend is in agreement
with our previous report36, and we speculate that this is probably
due to a good balance between polymer chain ﬂexibility and
rigidity. Moreover, HPAEs did not induce obvious cytotoxicity
(Supplementary Fig. 11). To explore the possible mechanism of
the good biocompatibility of HPAEs, the degradation of HPAE-3
was studied (Supplementary Methods). As shown in Supplemen-
tary Fig. 12, after 6 h of incubation in phosphate buffer solution
(PBS), the molecular weights of HPAE-3 and LPAE both
decreased obviously. The cytotoxicity of the degraded byproducts
of HPAE-3 was further evaluated. They exerted negligible
cytotoxicity; even if the concentration of degraded byproducts
was up to 250 μg mL−1, over 90% of cell viability was maintained
(Supplementary Fig. 13). All these data conﬁrm that HPAEs are
biodegradable and that the degraded byproducts are highly
biocompatible without inducing any obvious cytotoxicity during
the gene transfection process.
Integration of disulﬁde bonds to improve biodegradability.
Vector degradability matters for gene transfection by affecting
vector cytotoxicity and DNA release18,42,46. An intrinsic feature
that distinguishes poly(β-amino ester)s from other vectors is its
hydrolytic degradability in the physiological environment. How-
ever, the hydrolysis process is random and the duration ranges
from several hours to a few days, which would result in poorly
timed or off-target DNA release47,48, therefore spatiotemporally
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controlled DNA release is highly desired for gene transfection.
GSH is a natural tripeptide with a concentration inside cells of
around 2–10 mM while outside it is only 1–10 μM18,49. Cationic
polymers containing disulﬁde bonds in the backbone can main-
tain extracellular stability, but can be cleaved quickly upon cell
entry due to the high concentration of GSH causing the thiol-
disulﬁde interchange reaction. Numerous researches have incor-
porated disulﬁde bonds into cationic polymers to induce material
degradation and ultimate high-transfection efﬁcacy50–53. There-
fore, the integration of disulﬁde bonds into the backbone of
HPAEs is of great signiﬁcance for two reasons. Firstly, the
branched structure has demonstrated to have very strong DNA
condensation afﬁnity (Fig. 2a), which would potentially lead to
slow DNA release by hydrolysis. Secondly, the high-charge den-
sity (Fig. 2c) derived from the multiple terminal primary amines
could induce cytotoxicity. To realize this realm, disulfanediylbis
(ethane-2,1-diyl) diacrylate (DSDA) was introduced to the
monomer combination for HPAE-3 synthesis (Supplementary
Table 4 and Supplementary Fig. 14), and ﬁve disulﬁde-containing
HPAEs (HPAESSs) with different DSDA feed ratios were pro-
duced via Michael addition approach (Supplementary Table 5
and Supplementary Figs. 15 and 16).
We ﬁrstly used GPC and Picogreen assays to conﬁrm whether
HPAESSs can be cleaved by GSH to enhance DNA release. The
molecular weights of HPAESS-4 before and after incubation in
10 mM GSH solution for 1 h were shown in Fig. 4a. It is evident
that after incubation with GSH, the molecular weight of HPAESS-
4 substantially decreased from 16 to 6 kDa. In contrast, the
molecular weight of HPAE-3, a polymer without disulﬁde bonds
in the backbone, only decreased slightly from 14 to 13 kDa. In
HKC810:1 20:1 10:1 20:1
108
G
lu
cif
er
as
e 
ac
tiv
ity
(R
LU
/10
,00
0 c
ell
s) 107
106
105
104
100
Hela
G
FP
 p
os
itiv
e 
ce
lls
 (%
)
80
60
40
20
0
100 µm
200 µm
100 µm
200 µm
100 µm
200 µm
100 µm
200 µm
100 µm
200 µm
100 µm
200 µm
108
G
lu
cif
er
as
e 
ac
tiv
ity
(R
LU
/10
,00
0 c
ell
s) 107
106
105
104
LP
AE
HeLa
a
b
c
d
LPAE HPAE-1 HPAE-2 HPAE-3 HPAE-4 HPAE-5
HKC8
HeLa
100 101 104 106 107105103102
Ce
ll c
ou
nt
FL2-A
UT
LPAE
HPAE-1
HPAE-2
HPAE-3
HPAE-4
HPAE-5
HP
AE
-1
HP
AE
-2
HP
AE
-3
HP
AE
-4
HP
AE
-5
LP
AE
HP
AE
-1
HP
AE
-2
HP
AE
-3
HP
AE
-4
HP
AE
-5
PE
I
Su
pe
rFe
ct
Lip
o2
k
LP
AE
HP
AE
-1
HP
AE
-2
HP
AE
-3
HP
AE
-4
HP
AE
-5 PE
I
Su
pe
rFe
ct
Lip
o2
k
Fig. 3 HPAEs show much higher transfection efﬁcacy than LPAE and commercial reagents. a Gluciferase activity of HKC8 and HeLa cells after 48 h
transfection with different vectors at w/w ratios of 10:1 and 20:1. Data points marked with asterisks (*) are statistically signiﬁcantly higher relative to the
Lipo2k group. b Fluorescence images of HKC8 and HeLa cells 48 h post transfection with various vectors at the w/w ratio of 20:1. The scale bars for HKC8
cells represent 200 μm, for HeLa cells represent 100 μm. c The percentage of GFP-positive Hela cells after transfection, asterisk indicates signiﬁcantly
higher transfection efﬁciency in comparison with the LPAE group. d Representative histogram distributions of untreated (UT) HeLa cells and the ones after
transfection with HPAEs at the w/w= 20:1. Data are shown as average ± SD; n= 4
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agreement with the GPC results, Picogreen assays further showed
that in the presence of GSH, the DNA binding afﬁnity of
HPAESS-4 was signiﬁcantly dropped from 97 to 35%, in sharp
contrast with that of HPAE-3 (Fig. 4b). Moreover, at high
concentrations ( > 100 μg mL−1), HPAESS-4 preserved substan-
tially higher viability of primary astrocytes (Fig. 4c). Further, as
the content of disulﬁde bonds increased, HPAESSs showed
decreasing cytotoxicity (Fig. 4d). Similar to HPAEs, all the
HPAESSs could effectively condense DNA to form nano-sized
polyplexes with moderate surface charge (Supplementary Fig. 17).
As a consequence, as conﬁrmed by the Gluciferase activity
analysis and GFP measurements, the gene transfection efﬁciency
of HPAESSs is enhanced to a different degree by the introduction
of disulﬁde bonds and HPAESS-4 exhibits the highest efﬁciency
(Fig. 5). The fact that both enhanced DNA release and reduced
cytotoxicity can be achieved simultaneously makes this strategy
advantageous for the development of HPAE-based gene delivery
vectors, in terms of ease of integration and improved
performance.
Guanidinylation to facilitate polyplex cellular uptake. Cellular
uptake of polyplexes poses another key barrier for achieving high
gene transfection efﬁciency. In 2000, breakthrough studies by
Wender et al.54 discovered that arginine-rich cellular penetrating
peptides (CPPs) can form multiple hydrogen bonds with the
phosphate, carboxylate, or sulfate groups located on cell surfaces,
facilitating greater transportation of cargos (e.g., drug, DNA,
siRNA, protein, quantum dots etc.) across the cellular membrane.
Inspired by CPPs, a variety of non-viral gene vectors bearing
guanidine moieties have been developed55,56. The multivalence of
guanidine moieties can enhance polyplexes cellular membrane
afﬁnity and improve the cellular uptake efﬁciency of polyplexes.
Given that cellular uptake of polyplexes substantially affects the
overall gene transfection efﬁciency of poly(β-amino ester)-based
gene delivery systems, and the fact that HPAEs offer multiple
reaction sites for further functionalization, one can envisage that
guanidine groups can be incorporated to the peripheries of HPAE
to enhance the cellular uptake of polyplexes. To this end,
HPAESS-4 was selected for guanidinylation at a 10%, 30%, 60 and
100% degree (Supplementary Figs. 18 and 19, denoted as
HPAESG-1 to HPAESG-4, respectively). The gunidinylation did
not reduce the positive charges of HPAESS, instead, the
formulated HPAESG/DNA polyplexes exhibited a slightly bigger
size and comparatively higher zeta potential compared with the
HPAESS/DNA counterparts (Supplementary Fig. 20), which is in
accordance with previous studies55. Interestingly, some of the
HPAESG-1/DNA polyplexes manifested a polyhedral morphol-
ogy in comparison with that of the HPAESS/DNA counterparts
exhibiting a uniform toroidal morphology (Fig. 6a). The effects of
guanidinylation on promoting polyplex cellular uptake were
evaluated on HeLa cells using Cy3 as a ﬂuorescence reporter.
After 4 h of incubation, there were numerous HPAESG-1/Cy3-
DNA polyplexes inside the cells and the majority were
accumulating around the nucleus (Fig. 6b). In contrast, the
HPAESS-4/Cy3-DNA polyplexes showed a lower uptake efﬁ-
ciency. Furthermore, although the percentage of Cy3-positive
cells after treatment with different polyplexes was similar (Fig.
6c), HPAESG/DNA polyplexes mediated much stronger ﬂuores-
cence than the HPAESS-4/DNA counterparts (Fig. 6d). In
contrast to the previous report55, here as the guanidinylation
degree increased, the cellular uptake efﬁciency of HPAESG/DNA
polyplexes decreased. Correspondingly, Gluciferase activity of
cells after transfection with HPAESG library also gradually
decreased with HPAESG-1 showing the highest transfection
efﬁciency (Fig. 7). These results demonstrate that guanidinylation
can indeed enhance the afﬁnity of HPAESG/DNA polyplexes
with cells, however, it is not simply a case of more guanidinyla-
tion giving better transfection.
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HPAESG-1 shows high efﬁcacy in ADSCs and astrocytes. We
next transfected rADSC, hADSC, Neu7 astrocytes, and primary
astrocytes using optimized HPAESG-1. As shown in Supple-
mentary Fig. 21, HPAESG-1 exhibited high gene transfection
activity on all the cell types. An approximate 1–4 orders of
magnitude increase in transfection was shown compared to
LPAE, which was also 15–106-fold higher than that of PEI,
SuperFect and Lipo2k. For both hADSC and primary astrocytes,
the Gluciferase activity after transfection by HPAESG-1 was still
15–18-fold stronger than the Lipo2k. Such high gene transfection
performance by HPAESG-1 is outperformed most of the reported
polymer-based vectors. For instance, a previous study using a
cyclized poly(2-(dimethylami- noethyl) methacrylate)
(PDMAEMA) to transfect hADSCs and Neu7, showing that
Gluciferase activity of hADSC after transfection was only similar
or even slightly lower than that mediated by SuperFect and PEI57.
In another study, Gluciferase activity of Neu7 after transfection
with a bio-reducible DSP8 polymer at its optimal w/w ratio of 3:1
was slightly higher than that mediated by SuperFect16. In con-
trast, here, the Gluciferase activity of ADSCs and astrocytes after
transfection with HPAESG-1 is orders-of-magnitude higher than
that mediated by PEI, SuperFect and Lipo2k. The high
gene transfection capability of HPAESG-1 in ADSC and astro-
cytes was further compared with that of FuGENE, Xfect and
Lipofectamine 3000 (Lipo3000). As shown in Supplementary
Fig. 22, Gluciferase activity of rADSC and astrocytes after
transfection with HPAESG-1 at the w/w ratio of 20:1 was between
4.6 and 170-fold higher than that mediated by FuGENE, Xfect
and Lipo3000. Altogether, these results demonstrate the high
gene transfection capability of HPAESG-1 in neurodegenerative
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disease relevant cells. Furthermore, HPAESG-1 is well tolerated
by all cell types at the effective dosage, with at least 90% cell
viability being preserved, starkly contrasting the severe cytotoxi-
city induced by PEI, SuperFect and Lipo2k (Supplementary
Fig. 23).
HPAESG-1/MC DNA shows high efﬁcacy in ADSCs and
astrocytes. To further improve the transfection performance of
HPAESG-1, we optimized the DNA itself by constructing a MC
DNA encoding for GFP (MC GFP, 3.0 kbp). Interestingly, the
difference in plasmid size signiﬁcantly affects the physiological
characteristics of the formulated polyplexes. All the polyplexes
formulated from MC DNA showed an obviously smaller size in
comparison with the counterparts formulated from normally
sized 5.6 kbp GFP DNA (Supplementary Fig. 24). Across all the
cell types, MC GFP mediated substantially higher transfection
efﬁciency than the standard GFP regardless of gene vectors used;
HPAESS-4 and HPAESG-1 showed signiﬁcantly higher trans-
fection efﬁciency than the LPAE and Lipo2k, however, HPAESG-
1/MC GFP exhibited the most robust gene transfection efﬁciency:
in rADSC, hADSC, Neu7, and primary astrocytes, the efﬁciency
was 46%, 77%, 67%, and 52%, respectively (Fig. 8). These are very
promising results because previously, the highest transfection
efﬁciency of hADSCs achieved by Yang et al.58 was only 24%.
Similarly, previous multiple repeats of lipofection only achieved
19% transfection efﬁciency in primary astrocytes59. These results
show that HPAESG-1 in combination of MC DNA is capable of
enhancing the gene transfection efﬁciency of ADSCs and astro-
cytes signiﬁcantly. Moreover, HPAESG-1/MC GFP show high
biocompatibility, with over 90% of cell viability being maintained
(Supplementary Fig. 25).
High levels of nerve growth factor expression in astrocytes. The
intended application target of the HPAESG-1/MC DNA poly-
plexes is neurodegenerative diseases, and thus a therapeutic gene
—nerve growth factor (NGF) encoding plasmid PP NGF (7.7
kbp) and its MC construct MC NGF (3.7 kbp) were further
constructed and used for transfection in Neu7 and primary
astrocytes. NGF plays a critical protective role in the development
and survival of sympathetic, sensory and forebrain cholinergic
neurons by promoting neurite outgrowth and nerve cell recov-
ery60–62. Given the strong dependency of the neurons on NGF,
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effective delivery of NGF encoding plasmid to relevant cells to
promote NGF secretion is a promising strategy for gene therapy
of neurodegenerative diseases63–65. The PP NGF was synthesized
by subcloning the NGF fragment into the parental plasmid
MN511A1 (PPMN511A1, 7063 bp) (Supplementary Figs. 26 and
27). MC NGF was then produced in ZYCY10P3S2T E. coli using
the PhiC31 Integrase system (Fig. 9a and Supplementary Fig. 28).
There was a GFP tag in the plasmids, therefore, both the GFP and
NGF expression could be quantiﬁed with ﬂow cytometry and
ELISA (Supplementary Fig. 29), respectively. The most favorable
parameters for a high level of human beta-NGF expression was
ﬁrst identiﬁed and it was found that in general, a relatively higher
cell density, DNA dosage, longer transfection time, and serum-
free condition were more favorable for NGF accumulation in the
cell supernatant while no obvious cytotoxicity was induced. Fig-
ure 9 and Supplementary Fig. 30 showed that at the w/w= 20:1,
the GFP expression in Neu7 and primary astrocyte transfected by
HPAESG-1/MC NGF was up to 84.55% and 59.80%, respectively,
even higher than the HPAESG-1/ MC GFP counterpart as
reported above, which is likely due to the serum-free condition
used. In contrast, only 44.04% and 31.23% GFP expression was
achieved by the PP NGF. The NGF expression in the super-
natants of Neu7 and primary astrocytes after transfection with the
HPAESG-1/ MC NGF was measured to be at high levels as well,
which was 6.5- and 12.3-fold higher than that mediated by the
HPAESG-1/PP NGF counterparts (Fig. 9d and Supplementary
Fig. 30c). These results demonstrate not only the superiority of
MC DNA in gene transfection compared to normally sized
plasmids, but also the robust transfection capability of the
HPAESG-1/MC DNA polyplexes in delivering and mediating the
expression of therapeutic genes in neurodegenerative disease
relevant cells, highlighting its great applicability for potential
clinical gene therapy. Bioactivity of the secreted NGF was further
assessed by exploring its ability to promote neurite outgrowth in
pheochromocytoma cells (PC12), and thus conditioned cell cul-
ture experiments were carried out. PC12 cells were incubated
under four different conditions: standard PC12 cell culture media
(DMEM with high a glucose concentration, PC12 media group),
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standard Neu7 cell culture media (DMEM with a low glucose
concentration, Neu7 media group), conditioned Neu7 cell culture
media (media saved from Neu7 cells after transfection with
HPAESG-1/MC NFG, the concentration of NGF was determined
to be 26.9 ng mL−1, Conditioned Neu7 media group) and stan-
dard PC12 cell culture media but with 50 ng mL−1 recombinant
NGF (PC12+NGF group), respectively. As shown in Fig. 10,
after 7 days, the PC12 media group and Neu7 media group did
not show any neurite outgrowth (as expected when NGF is
absent). In contrast, clearly visible neurite outgrowth was detected
in the conditioned Neu7 media group and the PC12+NGF
group. Owing to the higher concentration of NGF, the PC12+
NGF media promoted the outgrowth of neurite more sig-
niﬁcantly, as evidenced by the higher number and longer neurites.
After 14 days of incubation, similar to the PC12+NGF media,
much more obvious neurite outgrowth was observed in the
conditioned Neu7 media group. However, although the cell
density increased substantially in the PC12 media group and
Neu7 media group, there was still no neurite outgrowth detected.
All these results demonstrate the high bioactivity of the NGF
produced by the astrocytes, which is secreted to the surrounding
environment. We also tried to directly transfect the PC12 with the
HPAESG-1/MC NGF polyplexes. At the w/w ratio of 20:1,
although around 18.76% GFP expression was observed, unfor-
tunately, very limited neurite outgrowth was detected, as shown
in Supplementary Fig. 31. This is because the level of NGF
expression in PC12 cells was too low as conﬁrmed by ELISA
(< 5.0 pg mL−1).
Discussion
If ex vivo or in vivo cell manipulation is to reach the clinical use,
the transfection efﬁciency and the safety of non-viral vectors have
to be drastically improved. Some of the most successful devel-
opments in the non-viral ﬁeld have been through the develop-
ment of poly(β-amino ester)s27,66. To date, most of this type of
polymers has been focused upon linear structures14,25. However,
we have recently shown that HPAEs may have a substantial
advantage over their linear counterpart36,37. Herein, we have
performed a stepwise modiﬁcation and optimization strategy to
break the hurdles of poor non-viral gene vectors.
In this work, we focused on two speciﬁc cell types relevant to
gene therapy strategies for neurodegenerative disorders: ADSCs
and astrocytes. Apart from the clinical implications of being able
b
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to transfect these cells, they were also chosen as a tough test bed
for the development of an efﬁcient vector. Using HKC8 and HeLa
cells for the optimization steps, an iterative modiﬁcation strategy
was employed to optimize HPAEs to navigate the key barriers of
gene transfection, including cytotoxicity, polyplex uptake, and
DNA release. We started with optimization of the branched
structure by synthesizing ﬁve HPAEs differing in branching
degree. Polyplex characterization and gene transfection indicate
that HPAEs with a moderate branching degree is more favorable
for transfection. Increasing amounts of disulﬁde bonds were
introduced into the backbone of HPAE-3, our results showed that
the degradability of HPAESS was enhanced, with a corresponding
increase in the rate of DNA release, and the cytotoxicity was
signiﬁcantly reduced. This work therefore corroborates that
shown with PEI by Breunig et al.67. HPAESS-4 was further
modiﬁed by guanidine for improved cellular penetrating ability.
Interestingly, the lower guanidinylation degree is more effective,
and at a high w/w ratio (e.g., 20:1) all the HPAESGs have similar
transfection capability.
Turning towards the cell types of interest, the leading polymer
from the third optimization step (HPAESG-1) was initially
evaluated using a standard DNA construct. Up to 106-fold higher
transfection efﬁciency was achieved by HPAESG-1 in comparison
with the commercial reagents, whilst over 90% cell viability was
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preserved. Having optimized the vector, it was then desired to
analyze whether a small DNA construct could add another layer
of synergistic improvement. The accessory sequences for propa-
gation of plasmid DNA can have adverse effects such as the viral/
bacterial sequence triggering immune responses, or the antibiotic
resistance sequences potentially transferring to the host68. Addi-
tionally, high level and long-term expression of functional pro-
teins is highly sought after for gene therapy, to avoid high cost
and repeated gene administrations. To this end, MC DNA con-
structs have been designed by removing the prokaryotic
sequences resulting in a supercoiled minimally sized DNA
cassette40,41,69.
When MC DNA was combined with HPAESG-1, high-
transfection efﬁcacy in rADSC, hADSC, Neu7 and primary
astrocytes was achieved, indicating the synergistic effects of vector
structure, degradability, functionalization and DNA construct. To
demonstrate the potential clinical applicability, a therapeutic MC
NGF was further constructed and it was found that high level of
NGF expression in astrocytes was achieved. Importantly, the NGF
showed high bioactivity to promote neurite outgrowth from PC12
cells. All these results demonstrate that the synergistic gene
delivery system comprising an optimized gene vector and an
optimal DNA construct can achieve robust transfection activity
and high safety simultaneously, implying the great potential of
this system in the treatment of neurological diseases. In addition,
given the ease of operation and versatility, our synergistic mod-
iﬁcation strategy may be used for the development of various
non-viral gene delivery vectors targeting diverse cell types and
diseases.
Methods
Iterative modiﬁcation and optimization of HPAEs. As outlined in Supplemen-
tary Table 1, to synthesize HPAE-1 to HPAE-5, the stoichiometric ratio of the
overall amines to acrylates was kept at 1:1.2. Monomers S4, TMPTA and BE with
varying ratios were dissolved in dimethyl sulfoxide (DMSO), respectively, to an
overall monomer concentration of 500 mgmL−1. The reaction occurred at 90 oC to
generate acrylate terminated base polymers. Afterwards, DMSO was added to
dilute the reaction mixture to 100 mgmL−1, and then a second amine DT was
added to end-cap the generated base polymers at room temperature for 48 h. To
purify the polymers, the reaction mixtures were precipitated into diethyl ether three
times. Polymers were collected, dried under vacuum for 24 h at room temperature
and then stored at −20 oC for the following studies. The corresponding linear
polymer LPAE, was prepared following the same procedures using bulk poly-
merization without triacrylate monomer TMPTA or the solvent DMSO.
The HPAE-3 was functionalized by introducing disulﬁde bonds to the
backbone. As outlined in Supplementary Table 4, the stoichiometric ratio of the
overall amines to acrylates was 1:1.2, TMPTA and S4 and the monomer feed ratios
were the same as above, while varying amounts of DSDA and BE were employed.
Five HPAEs that differed in the content of disulﬁde component, termed as
HPAESS-1 to HPAESS-5, respectively, were prepared as above. The HPAESS-4 was
further functionalized by introducing multiple guanidine groups at the periphery
primary amines (calculated to be 0.64 mmol g−1). Brieﬂy, 94 mg HPAESS-4 was
dissolved in DMSO, and then the guanidinylation agents 1H-pyrazole-1-
carboxamidine hydrochloride (HPCH) and N,N-diisopropylethylamine (DIPEA)
(in equivalent mole, 0.006, 0.018, 0.036, and 0.06 mmol, respectively) were added.
After 2 days of reaction at room temperature, the reaction mixtures were directly
dialyzed against DMSO for 3 days. The ﬁnal products, HPAESG-1 to HPAESG-4 of
10%, 30%, 60% or 100% guanidinylation degree, respectively, were lyophilized.
HPAESS degradation in the presence of GSH. Fifty milligram of polymers were
dissolved in 1 mL sodium acetate buffer, followed by addition of GSH solution (20
mM, 1 mL). The mixtures were kept stirring at room temperature (RT) for 1 h and
then lyophilized immediately. Molecular weights of the degraded products were
measured with GPC.
Polyplex size and zeta potential. To measure the size and zeta potential, poly-
plexes were ﬁrstly prepared by adding polymer solution into DNA solution at a 1:1
volume ratio, mixing and incubating for 10 min, 2 μg Gluc DNA was used for each
sample. The polyplexes were then diluted to 1 mL with PBS. Size and zeta potential
were measured with DLS and electrophoretic light scattering, respectively. To test
polyplex stability in the presence of protein, LPAE/DNA and HPAE-3/DNA
polyplexes (w/w= 20 :1) were prepared as above and then diluted to 1 mL with
BSA containing deionized water, the ﬁnal concentration of BSA was 0.5%. Size of
the polyplexes was measured with DLS immediately at 0, 0.5 and 1 h after pre-
paration, respectively.
Subcloning of NGF into PPMN511A1. The parental plasmid (PPMN511A1) was
used as a minicircle construction system (System Biosciences). The PPMN511A1
(vector, V) (7.0 kbp) was digested by XbaI and BamHI enzymes. Simultaneously,
XbaI and BamHI enzymes digestion sites were used to cut the human NGF gene
fragment (insert, I) (0.7 kbp) from pEX-A2-NGF plasmid, which was synthesized
by Euroﬁns. After the digestion, DNA was run on a 0.8% agarose gel in 1X tris-
acetate EDTA buffer (TAE) at 110 V for 1 h to separate NGF bands from the pEX-
A2 backbone band. Then NGF containing gel fragments was cut by a scalpel and
placed into a microcentrifuge tube. For successful ligations, NGF fragment was
then puriﬁed from agarose gel using advanced QIAEX II® Gel Extraction Kit. After
that, PPMN511A1 (V) and puriﬁed NGF fragment (I) were ligated using T4 DNA
Ligase at 1:3 molar ratio of V: I at 22 °C for 3 h, followed by inactivation at 70 °C
for 10 min. The ligation products were transformed into competent ZYCY10P3S2T
E. coli, and eight colonies were selected for screening from the agar plates with
kanamycin (50 µg mL−1). The NGF fragment was inserted into the PP (V) at a
position downstream of the CMV promoter. The new generated plasmid is the
PPMN511A1-NGF DNA (PP NGF, 7.7 kbp). The structure of the PP NGF was
determined by restriction digestion and electrophoresis analysis on 1% agarose gels.
MC NGF production. Highly pure MC NGF (3.7 kbp) under the control of CMV
promoter was produced as following: On the ﬁrst day, 20 µL of transformed ZYCY
E. coli with constructed PP NGF were cultured in 5 mL of lysogeny broth (LB)
media contains kanamycin (50 µg mL−1) at 37 °C under shaking (250 rpm) for 5 h
(starting culture). Following which, 400 mL of terriﬁc broth (TB) with kanamycin
(50 µg mL−1) was inoculated with 100 µL of the TB from the starting culture media
and incubated at 37 °C and 250 rpm shaking overnight. The next day, around 416
mL of MC Induction Mix (I.M.) (400 mL of LB, 16 mL of 1 N NaOH and 420 μL of
20% L-arabinose) was added and the culture media was incubated at 31 °C and
250 rpm shaking for 7 h. Next day, the bacterial cells contain MC NGF were
centrifuged at 4149 x g and the plasmid was puriﬁed following standard procedures.
The structure of the PP NGF and MC NGF were determined by restriction
digestion and electrophoresis analysis on 1% agarose gels.
Day 7
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PC12 media
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Fig. 10 Fluorescent images of PC12 after incubation with different media. Arrows indicate the outgrowth of neurite. The cell nucleus were stained with DAPI
(blue), F-actin was stained with Alexa Fluor 594 (red). The scale bars represent 50 μm
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Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data relevant to this study are available from the corresponding author upon
reasonable request.
Received: 11 November 2016 Accepted: 24 June 2019
References
1. Lindvall, O. & Kokaia, Z. Stem cells for the treatment of neurological
disorders. Nature 441, 1094–1096 (2006).
2. Bray, N. A second wave. Nat. Rev. Neurosci. 17, 76 (2016).
3. Barker, R. A., Drouin-Ouellet, J. & Parmar, M. Cell-based therapies for
Parkinson disease-past insights and future potential. Nat. Rev. Neurol. 11,
492–503 (2015).
4. Emerich, D. F., Orive, G., Thanos, C., Tornoe, J. & Wahlberg, L. U.
Encapsulated cell therapy for neurodegenerative diseases: from promise to
product. Adv. Drug Del. Rev. 67-68, 131–141 (2014).
5. Teixeira, F. G., Carvalho, M. M., Sousa, N. & Salgado, A. J. Mesenchymal stem
cells secretome: a new paradigm for central nervous system regeneration? Cell.
Mol. Life Sci. 70, 3871–3882 (2013).
6. Hoban, D. B., Howard, L. & Dowd, E. GDNF-secreting mesenchymal stem
cells provide localized neuroprotection in an inﬂammation-driven rat model
of Parkinson’s disease. Neuroscience 303, 402–411 (2015).
7. Hoban, D. B. et al. The reduction in immunogenicity of neurotrophin
overexpressing stem cells after intra-striatal transplantation by encapsulation
in an in situ gelling collagen hydrogel. Biomaterials 34, 9420–9429 (2013).
8. Pekny, M. et al. Astrocytes: a central element in neurological diseases. Acta
Neuropathol. 131, 323–345 (2016).
9. Chan, T. M. et al. ADSC therapy in neurodegenerative disorders. Cell
Transplant. 23, 549–557 (2014).
10. Tai, Y. T. & Svendsen, C. N. Stem cells as a potential treatment of neurological
disorders. Curr. Opin. Pharmacol. 4, 98–104 (2004).
11. Chang, K. A., Lee, J. H. & Suh, Y. H. Therapeutic potential of human adipose-
derived stem cells in neurological disorders. J. Pharmacol. Sci. 126, 293–301
(2014).
12. Dantuma, E., Merchant, S. & Sugaya, K. Stem cells for the treatment of
neurodegenerative diseases. Stem Cell Res. Ther. 1, 37 (2010).
13. Crook, J. M., Wallace, G. & Tomaskovic-Crook, E. The potential of induced
pluripotent stem cells in models of neurological disorders: implications on
future therapy. Expert Rev. Neurother. 15, 295–304 (2015).
14. Yang, F. et al. Genetic engineering of human stem cells for enhanced
angiogenesis using biodegradable polymeric nanoparticles. Proc. Natl Acad.
Sci. U.S.A 107, 3317–3322 (2010).
15. Tzeng, S. Y. et al. Non-viral gene delivery nanoparticles based on poly(beta-
amino esters) for treatment of glioblastoma. Biomaterials 32, 5402–5410
(2011).
16. Newland, B. et al. GDNF gene delivery via a 2-(dimethylamino)ethyl
methacrylate based cyclized knot polymer for neuronal cell applications. ACS
Chem. Neurosci. 4, 540–546 (2013).
17. Newland, B. et al. Untying a nanoscale knotted polymer structure to linear
chains for efﬁcient gene delivery in vitro and to the brain. Nanoscale 6,
7526–7533 (2014).
18. Bauhuber, S., Hozsa, C., Breunig, M. & Goepferich, A. Delivery of nucleic
acids via disulﬁde-based carrier systems. Adv. Mater. 21, 3286–3306 (2009).
19. Pack, D. W., Hoffman, A. S., Pun, S. & Stayton, P. S. Design and development
of polymers for gene delivery. Nat. Rev. Drug Discov. 4, 581–593 (2005).
20. Breunig, M., Lungwitz, U., Liebl, R. & Goepferich, A. Breaking up the
correlation between efﬁcacy and toxicity for nonviral gene delivery. Proc. Natl
Acad. Sci. U.S.A. 104, 14454–14459 (2007).
21. Liu, S. et al. Bioreducible zinc(II)-coordinative polyethylenimine with low
molecular weight for robust gene delivery of primary and stem cells. J. Am.
Chem. Soc. 139, 5102–5109 (2017).
22. Mintzer, M. A. & Simanek, E. E. Nonviral vectors for gene delivery. Chem.
Rev. 109, 259–302 (2009).
23. Guo, X. & Huang, L. Recent advances in nonviral vectors for gene delivery.
Acc. Chem. Res. 45, 971–979 (2012).
24. Wei, H., Schellinger, J. G., Chu, D. S. H. & Pun, S. H. Neuron-targeted
copolymers with sheddable shielding blocks synthesized using a reducible,
RAFT-ATRP double-head agent. J. Am. Chem. Soc. 134, 16554–16557 (2012).
25. Lynn, D. M. & Langer, R. Degradable poly(beta-amino esters): synthesis,
characterization, and self-assembly with plasmid DNA. J. Am. Chem. Soc. 122,
10761–10768 (2000).
26. Lynn, D. M., Anderson, D. G., Putnam, D. & Langer, R. Accelerated discovery
of synthetic transfection vectors: parallel synthesis and screening of degradable
polymer library. J. Am. Chem. Soc. 123, 8155–8156 (2001).
27. Akinc, A., Lynn, D. M., Anderson, D. G. & Langer, R. Parallel synthesis and
biophysical characterization of a degradable polymer library for gene delivery.
J. Am. Chem. Soc. 125, 5316–5323 (2003).
28. Green, J. J., Langer, R. & Anderson, D. G. A combinatorial polymer library
approach yields insight into nonviral gene delivery. Acc. Chem. Res. 41,
749–759 (2008).
29. Green, J. J. et al. Combinatorial modiﬁcation of degradable polymers enables
transfection of human cells comparable to adenovirus. Adv. Mater. 19,
2836–2842 (2007).
30. Li, C., Tzeng, S. Y., Tellier, L. E. & Green, J. J. 3-aminopropyl)-4-
methylpiperazine end-capped poly(1,4-butanediol diacrylate-co-4-amino-1-
butanol)-based multilayer ﬁlms for gene delivery. ACS Appl. Mater. Interfaces
5, 5947–5953 (2013).
31. Anderson, D. G., Akinc, A., Hossain, N. & Langer, R. Structure/property
studies of polymeric gene delivery using a library of poly(beta-amino esters).
Mol. Ther. 11, 426–434 (2005).
32. Sunshine, J. C., Akanda, M. I., Li, D., Kozielski, K. L. & Green, J. J. Effects of
base polymer hydrophobicity and end-group modiﬁcation on polymeric gene
delivery. Biomacromolecules 12, 3592–3600 (2011).
33. Anderson, D. G. et al. A polymer library approach to suicide gene therapy for
cancer. Proc. Natl. Acad. Sci. U. S. A. 101, 16028–16033 (2004).
34. Sunshine, J. et al. Small molecule end group of linear polymer determines cell-
type gene delivery efﬁcacy. Adv. Mater. 21, 4947–4951 (2009).
35. Lee, C. C., MacKay, J. A., Frechet, J. M. & Szoka, F. C. Designing dendrimers
for biological applications. Nat. Biotechnol. 23, 1517–1526 (2005).
36. Zhou, D. et al. The transition from linear to highly branched poly(beta-amino
ester)s: branching matters for gene delivery. Sci. Adv. 2, e1600102 (2016).
37. Cutlar, L. et al. Highly branched poly(beta-amino esters): synthesis and
application in gene delivery. Biomacromolecules 16, 2609–2617 (2015).
38. Huang, J. Y. et al. Tailoring highly branched poly(beta-amino ester)s: a
synthetic platform for epidermal gene therapy. Chem. Commun. 51,
8473–8476 (2015).
39. Zhou, D. et al. Highly branched poly(β-amino ester)s for skin gene therapy. J.
Control. Release 244, 336–346 (2016).
40. Darquet, A. M., Cameron, B., Wils, P., Scherman, D. & Crouzet, J. A new
DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther. 4,
1341–1349 (1997).
41. Bigger, B. W. et al. An araC-controlled bacterial cre expression system to
produce DNA minicircle vectors for nuclear and mitochondrial gene therapy.
J. Biol. Chem. 276, 23018–23027 (2001).
42. Zhao, T. Y. et al. Signiﬁcance of branching for transfection: synthesis of highly
branched degradable functional poly(dimethylaminoethyl methacrylate) by
vinyl oligomer combination. Angew. Chem. Int. Ed. 53, 6095–6100 (2014).
43. Sun, M., Hong, C. Y. & Pan, C. Y. A unique aliphatic tertiary amine
chromophore: ﬂuorescence, polymer structure, and application in cell
imaging. J. Am. Chem. Soc. 134, 20581–20584 (2012).
44. You, Y. Z., Yu, Z. Q., Cui, M. M. & Hong, C. Y. Preparation of
photoluminescent nanorings with controllable bioreducibility and stimuli‐
responsiveness. Angew. Chem. Int. Ed. 49, 1099–1102 (2010).
45. Patel, A. K. et al. Inhaled nanoformulated mRNA polyplexes for protein
production in lung epithelium. Adv. Mater. 31, 1805116 (2019).
46. Kozielski, K. L., Tzeng, S. Y., De Mendoza, B. A. & Green, J. J. Bioreducible
cationic polymer-based nanoparticles for efﬁcient and environmentally
triggered cytoplasmic siRNA delivery to primary human brain cancer cells.
ACS Nano 8, 3232–3241 (2014).
47. Sunshine, J. C., Peng, D. Y. & Green, J. J. Uptake and transfection with
polymeric nanoparticles are dependent on polymer end-group structure, but
largely independent of nanoparticle physical and chemical properties. Mol.
Pharm. 9, 3375–3383 (2012).
48. Kozielski, K. L., Tzeng, S. Y. & Green, J. J. A bioreducible linear poly(beta-
amino ester) for siRNA delivery. Chem. Commun. 49, 5319–5321 (2013).
49. Liu, S. et al. Biodegradable highly branched poly(β-amino ester)s for targeted
cancer cell gene transfection. ACS Biomater. Sci. Eng. 3, 1283–1286 (2017).
50. Elzes, M. R., Akeroyd, N., Engbersen, J. F. & Paulusse, J. M. Disulﬁde-
functional poly (amido amine) s with tunable degradability for gene delivery.
J. Control. Release 244, 357–365 (2016).
51. Ou, M., Xu, R., Kim, S. H., Bull, D. A. & Kim, S. W. A family of bioreducible
poly (disulﬁde amine) s for gene delivery. Biomaterials 30, 5804–5814 (2009).
52. Yu, H., Russ, V. & Wagner, E. Inﬂuence of the molecular weight of
bioreducible oligoethylenimine conjugates on the polyplex transfection
properties. AAPS J. 11, 445–455 (2009).
53. Oupický, D., Parker, A. L. & Seymour, L. W. Laterally stabilized complexes of
DNA with linear reducible polycations: strategy for triggered intracellular
activation of DNA delivery vectors. J. Am. Chem. Soc. 124, 8–9 (2002).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11190-0 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3307 | https://doi.org/10.1038/s41467-019-11190-0 | www.nature.com/naturecommunications 13
54. Wender, P. A. et al. The design, synthesis, and evaluation of molecules that
enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl
Acad. Sci. U.S.A. 97, 13003–13008 (2000).
55. Zhang, B., Ji, W., Liu, W. & Yao, K. Guanidinylated allylamine-N-
isopropylacrylamide copolymer nonviral transgene vectors. Int. J. Pharm. 331,
116–122 (2007).
56. Kim, T. I., Lee, M. & Kim, S. W. A guanidinylated bioreducible polymer with
high nuclear localization ability for gene delivery systems. Biomaterials 31,
1798–1804 (2010).
57. Newland, B. et al. Single cyclized molecule versus single branched molecule: a
simple and efﬁcient 3D “knot” polymer structure for nonviral gene delivery. J.
Am. Chem. Soc. 134, 4782–4789 (2012).
58. Yang, F. et al. Gene delivery to human adult and embryonic cell-derived stem
cells using biodegradable nanoparticulate polymeric vectors. Gene Ther. 16,
533–546 (2009).
59. Wu, B. Y., Liu, R. Y., So, K. L. & Yu, A. C. H. Multi-lipofection efﬁciently
transfected genes into astrocytes in primary culture. J. Neurosci. Meth. 102,
133–141 (2000).
60. Aloe, L., Rocco, M. L., Balzamino, B. O. & Micera, A. Nerve growth factor: a
focus on neuroscience and therapy. Curr. neuropharmacol. 13, 294–303
(2015).
61. Weissmiller, A. M. & Wu, C. Current advances in using neurotrophic factors
to treat neurodegenerative disorders. Transl. Neurodegener. 1, 14 (2012).
62. Lindsay, R. M. Neurotrophic growth factors and neurodegenerative diseases:
therapeutic potential of the neurotrophins and ciliary neurotrophic factor.
Neurobiol. Aging 15, 249–251 (1994).
63. Tuszynski, M. H. et al. Nerve growth factor gene therapy: activation of
neuronal responses in Alzheimer disease. JAMA Neurol. 72, 1139–1147
(2015).
64. Malkki, H. NGF gene therapy activates neurons in the AD patient brain. Nat.
Rev. Neurol. 11, 548 (2015).
65. Iulita, M. F. & Cuello, A. C. Nerve growth factor metabolic dysfunction in
Alzheimer’s disease and Down syndrome. Trends Pharmacol. Sci. 35, 338–348
(2014).
66. Anderson, D. G., Lynn, D. M. & Langer, R. Semi-automated synthesis and
screening of a large library of degradable cationic polymers for gene delivery.
Angew. Chem. Int. Ed. 42, 3153–3158 (2003).
67. Breunig, M. et al. Mechanistic investigation of poly(ethylene imine)-based
siRNA delivery: disulﬁde bonds boost intracellular release of the cargo. J.
Control. Release 130, 57–63 (2008).
68. Chen, Z. Y., He, C. Y., Meuse, L. & Kay, M. A. Silencing of episomal transgene
expression by plasmid bacterial DNA elements in vivo. Gene Ther. 11,
856–864 (2004).
69. Keeney, M. et al. Development of poly(beta-amino ester)-based biodegradable
nanoparticles for nonviral delivery of minicircle DNA. ACS Nano 7,
7241–7250 (2013).
Acknowledgements
This work was funded by Science Foundation Ireland (SFI) Principal Investigator Pro-
gram (13/IA/1962), National Natural Science Foundation of China (NSFC) (51873179)
and University College Dublin.
Author contributions
D.Z., W.W., S.L., Y.G., and B.N. designed the experiments. S.L., D.Z., Y.G., M.Z., F.A., J.
L., and F.Z. performed all the experiments. All the authors were involved in the analyses
and interpretation of the data. D.Z., S.L., Y.G., B.N., J.O.A., U.G., T.G., and W.W. wrote
the paper with the help of the co-authors.
Additional information
Supplementary Information accompanies this paper at https://doi.org/10.1038/s41467-
019-11190-0.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Peer review information: Nature Communications thanks anonymous reviewer(s) for
their contribution to the peer review of this work.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2019
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11190-0
14 NATURE COMMUNICATIONS |         (2019) 10:3307 | https://doi.org/10.1038/s41467-019-11190-0 | www.nature.com/naturecommunications
